Vaccinated Individuals Account for 34.6% of the Population

On the morning of the 4th, citizens are waiting for testing at the temporary COVID-19 screening site set up at Seoul Station Plaza in Jung-gu, Seoul. [Image source=Yonhap News]

On the morning of the 4th, citizens are waiting for testing at the temporary COVID-19 screening site set up at Seoul Station Plaza in Jung-gu, Seoul. [Image source=Yonhap News]

View original image


[Asia Economy Reporter Changhwan Lee] The cumulative number of people who received the first dose of the COVID-19 vaccine surpassed 30 million as of the 5th.


It has been 192 days since vaccinations began on February 26.


According to the COVID-19 Vaccination Response Promotion Team, the cumulative number of first-dose vaccinations was counted at 30,001,000 as of 11:15 a.m. on that day.


This corresponds to about 58.4% of the total population (51,349,116 as of last December). Considering only those aged 18 and over, who are eligible for vaccination, the rate is about 68.0%.


By vaccine type, the cumulative first-dose recipients are 15,238,048 for Pfizer, 11,078,221 for AstraZeneca, and 2,414,408 for Moderna.


The cumulative number of Janssen vaccine recipients is 1,266,142. People who received the Janssen vaccine, which requires only one dose, are included in both the first and second dose counts.


The number of people who have completed the full recommended doses by vaccine type is 17,747,159, accounting for 34.6% of the population.


As of midnight on that day, the total remaining vaccine doses in the country amounted to 12,835,200.


By vaccine type, there are 4,649,800 doses of Pfizer, 4,600,900 doses of AstraZeneca, 3,209,900 doses of Moderna, and 374,600 doses of Janssen.



As of midnight on that day, the reservation rate for the 18-49 age group was 72.2%, with 10,169,137 out of 14,085,068 eligible individuals having made reservations.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing